Kelso Pharma initiates European expansion with acquisition of Italian specialty pharma company, Velit Biopharma

Kelso Pharma (Kelso), the growing UK-based specialty pharma business, has taken its first step in its European expansion strategy by agreeing to acquire Italian specialty pharma company, Velit Biopharma (Velit). With more than 100 partnership agreements in place with pharma companies in Europe, Asia and the Middle East, Velit has a portfolio of more than […]
Kelso Pharma announces two UK product acquisitions as growth continues

Kelso Pharma, the growing UK-based specialty pharma business, has concluded a deal to acquire two UK approved products, representing an exciting launch into the specialty of Dermatology with prescription medicines for the treatment of actinic keratoses and plaque psoriasis. The two dermatology products, purchased from an organisation within the Dermapharm Group, represent another exciting move […]
<strong>Kelso Pharma announces first product launch</strong>

Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro® (Acetylcysteine) 600mg effervescent tablets. Acepiro (Acetylcysteine) is indicated in adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity […]
Kelso Pharma appoints Life Sciences leader as Chairman

Kelso Pharma, the growing specialty pharma business, has appointed senior Life Sciences executive, Gordon Cameron OBE, as its Non-Executive Chairman.
Kelso Pharma CEO featured in The Scotsman Scotland on Sunday ‘Business Big Interview’

Kelso Pharma CEO, Dr. Tom Stratford, was recently featured in The Scotsman Scotland on Sunday ‘Business Big Interview’. Tom discusses his early career, his entrepreneurial motivations, and what the future holds for Kelso Pharma. You can read the full interview with Tom here.
Kelso Pharma at home in Scotland’s capital

The Kelso Pharma team announces the establishment of its first office space in Edinburgh, Scotland.